United Kingdom Antacid Market Size, Share, and COVID-19 Impact Analysis, By Formulation (Tablet, Capsules, Powder, Liquid), By End-use (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), and United Kingdom Antacid Market Insights, Industry Trend, Forecasts to 2035.

United Kingdom Antacid Market Insights Forecasts to 2035

• The United Kingdom Antacid Market Size was estimated at USD 410.45 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.08% from 2025 to 2035
• The United Kingdom Antacid Market Size is Expected to Reach USD 871.34 Million by 2035

According to a research report published by Spherical Insights & Consulting, the United Kingdom Antacid Market Size is anticipated to reach USD 871.34 Million by 2035, growing at a CAGR of 7.08% from 2025 to 2035. Antacid market share is being positively impacted by the growing number of patients with gastroesophageal reflux disease (GERD) and the growing availability of over-the-counter medications in pharmacies, supermarkets, and online marketplaces.

Market Overview

The United Kingdom antacid market refers to the industry focused on the production and application of medications designed to neutralize stomach acid and relieve symptoms such as acid reflux, heartburn, indigestion, and ulcers. Antacids are basic and raise the pH level of stomach contents, mitigating acidity and addressing discomfort associated with elevated stomach acid levels, which are acidic. Antacids are an accessible option as they can be obtained without a prescription, allowing individuals to self-treat mild symptoms conveniently. They are widely available over the counter in various forms, including tablets, liquids, and chewable tablets. They offer quick and symptomatic relief. The benefits of antacids include their rapid efficacy, over-the-counter availability, and diverse formulations catering to individual preferences. In addition, a sedentary lifestyle and irregular eating habits are causing gastrointestinal discomfort, which prompts quick fixes and fuels this wide adoption.

Report Coverage

This research report categorizes the market for the United Kingdom antacid market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom antacid market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom antacid market. 
 

Driving Factors

The market for United Kingdom antacid is primarily driven by the gastroesophageal reflux disease (GERD) and an older population that is more susceptible to digestive diseases. OTC antacid sales increased significantly, particularly in urban areas that offer alternatives the prescription drugs for quick relief, and this is supported by a fast work life cycle. Moreover, e-commerce platforms could also be vital for antacid sales online and fuel the market expansion. The industry expansion is propelled by the rising demand for self-care products. Additionally, the regulatory environment in the UK guarantees the effectiveness and safety of antacid products, which promotes consumer confidence and industry expansion. 
 

Restraining Factors

The market expansion is hampered by their side effects, including the potential for diarrhea and constipation. Minerals like magnesium or aluminum may affect bone health. Rash, swelling, or trouble breathing are uncommon allergic reactions, and because they provide short-term relief from heartburn and indigestion, antacids may also help hide a more serious underlying disease.

Market Segmentation

The United Kingdom antacid market share is classified into formulation and end use.

• The liquid segment held a significant share in 2024 and is expected to grow at a rapid pace over the forecast period.

The United Kingdom antacid market is segmented by formulation into tablet, capsules, powder, and liquid. Among these, the liquid segment held a significant share in 2024 and is expected to grow at a rapid pace over the forecast period. This is because of its tasty flavor; the liquid dose form is one of the most popular options for both aging adults and youngsters. Further, liquid formulations absorb more quickly, they are also preferred for providing instant relief from illnesses like GERD and heartburn. The demand for liquid antacid will rise as producers continue to create more practical and efficient dosage forms, bolstering segment position in the market.

• The retail pharmacy segment accounted for the highest share in 2024 and is anticipated to grow at a substantial CAGR during the forecast period.

The United Kingdom antacid market is segmented by end use into retail pharmacy, hospital pharmacy, and online pharmacy. Among these, the retail pharmacy segment accounted for the highest share in 2024 and is anticipated to grow at a substantial CAGR during the forecast period. This is because of chain pharmacies and independent pharmacies of retail pharmacies and they offer handy placement in neighborhoods with their extended hours or 24-hour availability. Consultations with pharmacists improve the client experience in general. Customers choose retail pharmacies because of their extensive selection of pharmaceuticals, convenience, and individualized service.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom antacid market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• GlaxoSmithKline (GSK)
• Haleon
• WellSpring Pharmaceutical Corporation
• Reckitt Benckiser Group plc
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom antacid market based on the below-mentioned segments:

United Kingdom Antacid Market, By Formulation

• Tablet
• Capsules
• Powder
• Liquid

United Kingdom Antacid Market, By End Use

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy